SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-23 20:01 UTC

Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Drave…